No Data
RemeGen Deploys Idle Funds Into HTSC Wealth Products in Discloseable Transaction
Rongchang Bio (09995) proposes to elect directors for the third board of directors.
Rongchang Bio (09995) announced that the board held a meeting on May 18, 2026, to propose the election of directors for the third board of directors (excluding independent non-executive directors).
Shenwan Hongyuan Keeps Their Buy Rating on RemeGen Co. Ltd. Class H (9995)
RemeGen Invests in Wealth Management Products
REMEGEN(09995.HK):IMPROVING FINANCIAL PERFORMANCE WITH SUCCESSFUL BD COLLABORATION ACHIEVED
MSCI China Quarterly Adjustment: Optical Communication Dominates, While Old Economy and Consumer Electronics Decline
On May 12, 2026, MSCI, the global index giant, announced the quarterly review results of its Global Standard Index, which will officially take effect after the market close on May 29.